Latest Intelligence on Pharmaceuticals and Healthcare in Croatia

Select information type

Refine your search

search
Search tips

by industry

Published within

« | 1 | » »|

Type Product title / description Pub Price
Expert View
Expert View

Pliva props up the Barr

Adding to a wave of recent consolidation, Pliva has nominated US generics company Barr as its 'preferred bidder' as rivals line up to acquire the Croatian generics maker. As Datamonitor healthcare strategy analyst Dr Mark Belsey investigates, this looks like a good opportunity for Barr, which suffered a drop in sales of 19% from 2004-05 and needs this deal to revive its flagging sales performance.

Published By Datamonitor
28 Jun 2006
CommentWire
CommentWire

GlaxoSmithKline: Pliva deal to boost R&D

GlaxoSmithKline has entered into a deal to buy Pliva's state-of-the-art R&D facility Pliva-Istrazivacki Institut. Having recently reported an annual profit of GBP6.7 billion, Europe's biggest drugmaker will now hope to improve this financial performance by moving its research activities to lower-cost emerging markets.

Published By Datamonitor
15 Feb 2006

« | 1 | » »|

No help is available.